[ad_1] The NMR spectroscopy market is poised for expansion, driven by innovations such as increased magnetic field strengths and cryogenically cooled probes, which enhance sensitivity and resolution for in-depth molecular analysis. The adoption of automated, […]

[ad_1] The demand for heparin is mainly increasing due to the growing incidence of cardiovascular diseases, the expanding range of cancer risk factors such as smoking, radiation exposure, unhealthy lifestyles, and other factors, as well […]

[ad_1] The market size of chronic venous insufficiency is expected to increase during the forecast period with the increasing prevalence, disease awareness, and promising emerging treatment options by leading companies such as Verigraft AB, enVVeno […]

[ad_1] The increasing global incidence of gastric cancer is a major factor driving the demand for gastric cancer diagnostics. The market is also being fueled by the rising prevalence of GERD and other stomach-related conditions, […]

[ad_1] Following achievements in Asia, Roche’s PNH treatment drug PIASKY (crovalimab) received its first FDA approval. This approval has spiked the competition between Roche and current market leader AstraZeneca. Additionally, the other pharma companies also […]